AdamsP., ChalmersT. M., HillL. F., TruscottB. M. N.: Idiopathic hypercalciuria and hyperparathyroidism. Brit. Med. J., 4; 582 (1970).
2.
AlbrightF., HennemanP. H., BenedictP. H., ForbesA. P.: Idiopathic hypercalciuria Proc. R. Soc. Med., 46; 1077 (1953).
3.
AndersonJ., LeeH. A., TomlinsonR. W. S.: Some metabolic aspects of idiopathic hypercalciuria. Nephron, 4; 129 (1967).
4.
BirgeS. J.: Study of calcium absorption in man: a kinetic analysis of phyisiological model. J. Clin. Invest., 48; 1705 (1969).
5.
BirgeS. J., SwitzerS. C., LeonardD. R.: Influence of sodium and parathyroid hormone on calcium release from intestinal mucosal cells. J. Clin. Invest., 54; 702 (1974).
6.
BlacklockN. J., MacLeodM. A.: The effect of cellulose phosphate on intestinal absorption and urinary excretion of calcium. Some experiences in its use in the treatment of calcium stone formes. Brit. Urol., 46; 385 (1974).
7.
BordierP., RjckewartA., GuerisJ., RasmussenN.: On the pathogenesis of so-called idiopathic hypercalciuria. Amer. J. Med., 63; 398 (1977).
CoburnS. W., MassryS. G.: Changes in serum and urinary calcium during phosphate depletion. J. Clin. Invest., 49; 1703 (1970).
10.
CoeF. L.: Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria or no metabolic disorder. Ann. Intern. Med., 87; 404 (1977).
11.
CoeF. L., FirpoJ. J., ReissE.: Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J. Clin. Invest., 52; 134 (1973).
12.
CoeF. L., KavalachA. G.: Hypercalciuria and hyperparathyroidism in patients with calcium nephrolithiasis. N. Engl. J. Med., 291; 1344 (1974).
13.
CoeF. L., KeckJ., NortonE. R.: The natural hystory of calcium urolithiasis. J.A.MA.238; 1519 (1977).
14.
CoeF. L., LawtonR. L., GoldsteinR. B., TembeV.: Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc. Soc. Exp. Biol. Med., 149; 926 (1975).
15.
DaviesD. R.DentC. E., WatsonL: Idiopathic hypercalciuria and hyperparathyroidism. Brit. Med. J., 1; 108 (1971).
16.
De LucaH. F.: The kidney as an endocrine organ involved in the function of vitamin D. Amer. J. Med., 58; 30 (1975).
17.
DempseyE. F., CarrollE. L., AlbrightF., HennemanP. H.: Study of factors determining fecal electrolyte excretion. Metabolism, 7; 108 (1958).
18.
DentC. E.: Some problem of hyperparathyroidism. Brit. Med. J., 2; 1419 (1962).
19.
DentC. E., WatsonL.: Metabolic studies in a patient with idiopathic hypercalciuria. Brit. Med. J., 2; 449 (1965).
20.
EdwardsN. A., HodgkinsonA.: Metabolic studies in patients with idiopathic hypercalciuria. Clin. Sci., 29; 143 (1965).
21.
FialkowP. J., JacksonC. E., BlockM. A., GreenawaldK. A.: Multicellular origin of paratyroid «adenomas». N. Engl. J. Med., 297; 696 (1977).
22.
FlocksR. H.: Calcium and phosphorus excretion in the urine of patients with renal or ureteral calculi. J.A.M.A., 114; 1466 (1939).
23.
FlocksR. H.: Profylaxis and medical management of calcium urolithiasis: role of quantiy and precipitability of urinary calcium. J. Urol., 44; 183 (1940).
24.
GarabedianM., HolickM. F., De LucaH. F., BoyleI. T.: Control of 25-hydroxy-cholecalciferol metabolism by parathyroid glands. Proc. Nat. Acad. Sci. U.S.A., 69; 1673 (1972).
25.
GrayR. W., WilzD. R., CaldasA. E., LemannJ.jr.: The importance of phosphate in regulating plasma 1,25–(OH)2 vitamin D levels in humane: study in healthy subjects, in calcium - stone formers and in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metabol., 45; 299 (1977).
26.
HallsonP. C.: Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment. Brit. J. Urol., 48; 515 (1976).
27.
HallsonP. C.: Seasonal variations in urinary excretion of calcium and oxalate in normal subjects, in patients with idiopathic hypercalciuria. Brit. J. Urol., 49; 1 (1977).
28.
HarrisonA. R.: Some results of metabolic investigations in cases of renal stones. Brit. J. Urol., 31; 298 (1959).
29.
HarrisonJ. E.: Rat intestinal calcium-binding proteins. Can. J. Physiol. Pharmacol., 55; 595 (1977).
30.
HausslerM. R., McCainT. A.: Basic and clinical concepts related to vitamin D metabolism and action. N. Engl. J. Med., 297; 974, I parte; 1041, II parte (1978).
31.
HausslerM. R., BursacK. M., BoneH., PakC. Y. C.: Increased circulating 1,25-di-OH cholecalciferol in patients with primary hyperparathyroidism. Clin. Res., 23; 322A (1975)
32.
HayashiY., KaplanR. A., PakC. Y. C.: Effects of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism, 24; 1273 (1975).
33.
HeaneyR. P., BauerG. C. H., BronnerF., DyalingJ. P., LaffertyF. W., NordinB. E. C., RichC.: A normal reference standard for radiocalcium turnover and excretion in human. J. Lab. Clin. Med., 64; 21 (1964).
34.
HeaneyR. P., SK. SkilmanT. G.: Secretion and excretion of calcium by the human gastrointestinal tract. J. Lab. Clin. Med., 64; 29 (1964).
35.
HennemanP. H., BenedictP. H., ForbesA. P.DudleyH. R.: Idiopathic hypercalciuria. N. Engl. J. Med., 259; 802 (1958).
36.
HennemanP. H., DempseyE. F., CarrollE. L., AlbrightF.: Cause of hypercalciuria in sarcoid and its treatment with cortisone and sodium phytate. J. Clin. Invest., 35; 1229 (1956).
37.
HodgkinsonA.: Idiopathic hypercalciuria. Proc. Ass. Clin. Biochem., 1; 52 (1961).
38.
HodgkinsonA.: The relation between citric acid and calcium metabolism with particular reference to primary hyperparathyroidism and idiopathic hypercalciuria. Clin. Sci., 24; 167 (1963).
39.
HodkinsonA., PjrahL. N.: The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stones of renal origin. Brit. J. Surg., 46; 10 (1968).
40.
HughesM. R., BrumbaughP. F., HausslerM. R., WergedalJ. E., BaylinkD. J.: Regulation of serum 1.25-(OH)2-cholecalciferol by calcium and phosphate in the rat. Science. 190; 578 (1975).
41.
IssenJ., FeiglP.: Bancroft's introduction to Biostatistics (II ed.). Harper & Row, New York1970, p. 55.
42.
JacksonW. P. U, DacasterL.: A consideration of the hypercalciuria in sarcoidosis, idiopathic hypercalciuria and that produced by Vitamin D. A new suggestion regarding calcium metabolism. J. Clin. Endocrinol. Metab.19; 658 (1959).
KaminskyN. I., BroadusA. E., HardmanJ. G., JonesD. J., BallS. H., SutherlandE. N., LiddleG. W.: Effects of parathyroid hormone on plasma and urinary adenosine 3,5 monophosphate in man. J. Clin. Tnvest., 49; 2387 (1970).
45.
KaplanR. A., HausslerR., DeftosL. T.BoneH.PakC. Y. C.: The role of 1,25-di-hydroxyvitamin D in the mediation of intestinal hyperparabsorption of calcium in primary hyperparathyroidism and absorptive hvpercalciuria. J. Clin. Invest., 59; 756 (1977).
46.
KaplanR. A., PakC. Y. C.: Diagnosis and managemente of renal calculi. Tex. Med., 70; 88 (1974).
47.
LemanJ.jr., DominguezJ. H., GrayR. W.: Idiopathic hypercalciuria: a defect in phosphate and vitamin D metabolism?Proc. Intern. Colloq. on Ren. Lith - Univ. of Gainesville (1975).
48.
LetterS.: Simple test for hypercalciuria. N. Engl. J. Med., 292; 1134 (1975).
49.
LibermanU. A., SperlingO., AstmonA., FrankM., ModanM., De Vries: A metabolic and calcium kinetic studies idiopathic hypercalciuria. J. Clin. Invest., 47; 2580 (1968).
50.
LichtwitzA., de SèzeS., HiocoD., ParlierR., LanhamC., MirametL.: Physiopathologie et traitement des formes rénales et entérorénales du diabète calcique. Sém. Hôp. Paris., 37; 674 (1976).
51.
MassryS. G., CoburnJ. W.: The hormonal and non hormonal control of renal excretion calcium and magnesium. Nephron, 10; 66 (1973).
52.
MerceronR. E.: Étude étiopathogénique de l'hypercalciurie idiopathique. Ann. Med. Inter., 128; 421 (1977).
53.
MuradF., PakC. Y. C.: Urinary excretion of cAMP and cGMP. J. Clin. Invest., 49; 2387 (1970).
54.
NassimJ., HigginsB. A.: Control of idiopathic hypercalciuria. Brit. Med. J., 1; 675 (1965).
55.
NordinB. C., GlassN., SmithD.,. MacGregorJ., NisbetJ., BurnsH. G.: Bone formation and resorption rates in various clinical state - da: Medical Uses of Ca47. Intern. At. Energy Agency, Tech. Rept. Ser., 32; 75 (1964).
56.
NordinB.E.C., PeackockM., WilkinsonP.: Hypercalciuria and calcium stone disease. Clin. Endrocrinol. Metab., 1; 69, McIntyre, editor W. B. Saunders Co., Priladelphia U.S.A. 1972.
57.
NormanA. W.: Interrelationships between key elements of the vitamin D endocrine system: 25-OH-D3-1-hydroxylase, serum calcium and phosphorus levels intestinal 1,25.(OH)2-D3 and intestinal calcium. Adv. Exp. Med. Biol., 81; 15 (1977).
58.
PakC. Y. C: Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J. Clin. Invest., 48; 1914 (1969).
59.
PakC. Y. C: Effect of cellulose phosphate and of sodium phosphate on formation product and activity product of brushite in urine. Metabolism, 21; 447 (1972).
60.
PakC. Y. C: Hydrochlorothiazide therapy in nephrolithiasis effect on urinary activity product and formation product of brushite. Clin. Pharm. Ther., 14; 209 (1973).
61.
PakC. Y. C: Sodium cellulose phosphate: mechanism of action and effect on mineral metabolism. J. Clin. Pharm. New Drug, 13; 15 (1973).
62.
PakC. Y. C: Calcareous renal stones. Medcom, New York1973.
63.
PakC. Y. C: Physicochemical and clinical aspects of nephrolithiasis. Symp of Internat. Colloq. on Ren. Lith Univ. of Fla Gainesville (1974).
64.
PakC. Y. C: Calcareous renal calculi: current medical treatment. Tew. med., 72; 70 (1976).
PakC. Y. C, ArnoldL. H.: Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc. Soc. Exp. Biol. Med., 149; 930 (1975).
67.
PakC. Y. CDeleaC. S., BartterF. C.: Succesful treatment of recurrent nephrolithiasis (Calcium stones) with cellulose phosphate. N. Engl. J. Med., 290; 175 (1974).
68.
PakC. Y. C, EastD. A., SanzerbacherL. J.DeleaC. S., BartterF. C.: Gastrointestinal calcium absorption in nephrolithiasisJ. Clin. Endocrinol. Metab., 35; 261 (1972).
69.
PakC. Y. C, HoltK.: Nucleation and growth of Brushite and calcium oxalate in urine of stones-formers. Metabolism. 25; 665 (1976).
70.
PakC. Y. C, KaplanR., BoneH., TownsendJ., WatersO.: A simple test for diagnosis of absorbitive, resorptive and renal hypercalciuria. N. Engl. J. Med., 292; 497 (1975).
71.
PakC. Y. C,. OhataM., LawrenceE. C., SnyderW.: The hypercalciurias: causes, parathyroid function, and diagnostic criteria. J. Clin. Invest., 54; 387 (1974).
72.
PakC. Y. C, RuskinB., DillerE.: Enhancement of renal excretion of zinc by hydroclorothiazide. Clin. Chim. Acta.39; 511 (1972).
73.
ParfittM. M., HigginsB. A.NassimJ. R., CollinsJ. A.HilbA.: Metabolic studies in patients with hypercalciuria. Clin. Sci., 27; 463 (1959)
74.
RasmussenH., WongM.BikleD.GoodmanD. B. P.: Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1.25-dihydroxvcholecalciferol. J. Clin. Invest., 51; 2502 (1972).
75.
BibovichM. L.: Intestinal calcium transport. PTH and adaptation to dietary calcium. Arch. Bioch. Biophys., 175; 256 (1976).
76.
RitzE.: Pathophisiology and therapy of hypercalciuria in patients who form recurrent stones. Eur. Urol.1; 131 (1975).
77.
RizzoliR., FleischH., BoniourJ. P.: Role of 1,25-dihydroxyvitamin D on intestinal absorption in rats with a normal vitamin D supply. J. Clin. Invest., 60: 639 (1977).
78.
RobertsonW. G., PeacockM., MarschallR. W., MarshallD. H., NordinB. E. C.: Saturation inibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N. Engl. J. Med., 294; 249 (1976).
79.
RobertsonW. G., PeacockM., NordinB. E. C.: Inhibitors of the growth and aggregation of calcium oxalate crystals «in vitro». Clin. Chim. Acta, 43; 31 (1973).
80.
ScrottH. G., JubizW., FraileyJ.: Calcium infusion and phosphate deprivation test in patients with primary hyperparathyroidism and with normocalcemic nephrolithiasis. Metabolism, 21; 205 (1972).
81.
ShenF., BaylinkD. J., NielsonR., HugesM., HausslerM. R.: Increased serum 1,25-di-OH-cholecalciferol in patients with idiopathic hypercalciuria. Clin. Res., 23; 423A (1975).
82.
ShenF., BaylinkD. J., SherandD. S., HausslerM. R.: Idiopathic hypercalciuria the «phosphate leak» hypotesis and the effects of oral phosphate supplement. Clin. Res., 25; 129A (1977).